Anteris Technologies Global Corp. Common Stock (AVR) Stock Price

AVRStock

$8.89+112.05%52W

Market Cap$866.41M

P/E—

PEG Ratio—

Div yield—

Beta1.92

AVR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)42.60%

Price vs S&P 500 (4W)4.66%

VGM Score36.39

Book Value / Share (Quarterly)$2.86

P/TBV (Annual)3.21x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-15.77%

Cash Flow / Share (Quarterly)$-0.89

Price vs S&P 500 (YTD)64.39%

Gross Margin (TTM)74.28%

Net Profit Margin (TTM)-5148.78%

EPS (TTM)$-2.21

10-Day Avg Trading Volume0.81M

EPS Excl Extra (TTM)$-2.21

EPS (Annual)$-2.55

ROI (Annual)-121.55%

Gross Margin (Annual)70.26%

Cash / Share (Quarterly)$2.91

Revenue Growth QoQ (YoY)-11.15%

ROA (Last FY)-409.38%

Revenue Growth TTM (YoY)-0.54%

EBITD / Share (TTM)$-1.94

Operating Margin (TTM)-5192.92%

Cash Flow / Share (Annual)$-1.92

P/B Ratio3.13x

P/B Ratio (Quarterly)1.94x

Net Income / Employee (Annual)$-541,100

EV / Revenue (TTM)317.57x

Net Interest Coverage (TTM)-1057.71x

ROA (TTM)-101.21%

EPS Incl Extra (Annual)$-2.55

Current Ratio (Annual)0.73x

Quick Ratio (Quarterly)20.80x

3-Month Avg Trading Volume1.12M

52-Week Price Return112.05%

Revenue / Employee (TTM)$10,600

Tangible BV / Share (Quarterly)$2.86

P/S Ratio (Annual)454.94x

Asset Turnover (Annual)0.08x

52-Week High$11.05

EPS Excl Extra (Annual)$-2.55

26-Week Price Return53.85%

Quick Ratio (Annual)0.70x

13-Week Price Return-2.22%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)20.93x

Enterprise Value$587.82M

Asset Turnover (TTM)0.02x

Revenue / Employee (Annual)$11,000

Inventory Turnover (Annual)1.71x

Pretax Margin (Annual)-4925.51%

Cash / Share (Annual)$0.30

3-Month Return Std Dev54.94%

Net Income / Employee (TTM)$-547,700

ROE (Last FY)-121.56%

Net Interest Coverage (Annual)-138.88x

EPS Basic Excl Extra (Annual)$-2.55

Receivables Turnover (TTM)8.81x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.21

Receivables Turnover (Annual)15.94x

ROI (TTM)-64.41%

P/S Ratio (TTM)470.18x

Revenue / Share (Annual)$0.05

Tangible BV / Share (Annual)$1.74

Price vs S&P 500 (52W)93.74%

Year-to-Date Return76.35%

5-Day Price Return-8.14%

EPS Normalized (Annual)$-2.55

Net Profit Margin (Annual)-4921.28%

Month-to-Date Return12.24%

EBITD / Share (Annual)$-2.50

Operating Margin (Annual)-4908.21%

LT Debt / Equity (Annual)0.00x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-2.21

P/TBV (Quarterly)1.94x

P/B Ratio (Annual)3.20x

Inventory Turnover (TTM)1.96x

Pretax Margin (TTM)-5116.15%

Book Value / Share (Annual)$1.75

Price vs S&P 500 (13W)-5.02%

Beta1.92x

Revenue / Share (TTM)$0.02

ROE (TTM)-64.69%

52-Week Low$3.30

vGradeF

gGradeD

mGradeB

vgmGradeD

AVR Earnings Surprise History

Q2 25-0.58est. -0.48

Q3 25-0.62est. -0.57

Q4 25-0.75est. -0.56

Q2 26-0.30est. -0.21

AVR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.89
ISRGIntuitive Surgical Inc.	D	B	D	$371.84
EWEdwards Lifesciences Corp	D	C	B	$90.87
STESTERIS plc	C	B	C	$236.44
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$100.24
SNNSmith & Nephew plc	B	C	D	$29.22
ALGNAlign Technology Inc	B	D	C	$159.61
MSAMine Safety Incorporated	C	C	C	$187.69
ESTAEstablishment Labs Holdings Inc.	F	A	C	$72.15
ENOVEnovis Corporation	B	D	C	$25.58
CDRECadre Holdings, Inc.	C	C	C	$31.39
AVNSAvanos Medical, Inc.	B	D	C	$24.99
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.67
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	C	$2.77
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.55
INGNInogen Inc	B	D	D	$5.54
LAKELakeland Industries Inc	B	D	C	$11.52
SPAISafe Pro Group Inc. Common Stock	F	C	B	$5.25
NTRBNutriband Inc. Common Stock	F	D	B	$4.83
MYOMyomo Inc.	C	B	B	$1.48
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	C	$0.75
APTAlpha Pro Tech, Ltd.	A	D	C	$5.36
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.48
LFWDLifeward Ltd. Ordinary Shares	B	D	C	$7.39
RGNTRegentis Biomaterials Ltd.	—	—	C	$2.09
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$2.92
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	F	$0.29
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.39
BBLGBone Biologics Corp Common Stock	—	—	F	$0.60
BBLGWBone Biologics Corp Warrants	—	—	D	$8.24
COCHWEnvoy Medical, Inc Warrant	—	—	F	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	F	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.50

About Anteris Technologies Global Corp. Common Stock

Anteris Technologies Global Corp develops minimally invasive medical devices for structural heart disease, with its DurAVR Transcatheter Heart Valve as the flagship product. The balloon-expandable valve treats aortic stenosis through a biomimetic design that mimics the performance of a healthy human aortic valve. The company operates primarily in the United States, with additional presence in Germany, Australia, Switzerland, and Sweden.